Compounds > clindamycin

clindamycin and rokitamycin

clindamycin has been researched along with rokitamycin in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (50.00)	18.2507
2000's	2 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (16.67)	2.80

Authors

Authors	Studies
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Mitsuhashi, S; Okubo, T; Terasawa, T; Watanabe, M	1
Iwamoto, Y; Miyake, Y; Okuda, K; Suginaka, H; Tsuruda, K	1
Hirakata, Y; Igari, J; Kaku, M; Matsuda, J; Misawa, N; Mori, T; Murase, M; Nakamura, A; Nakamura, Y; Oguri, T; Shimada, J; Shimoura, M; Shitara, M; Tachibana, Y; Tazawa, S; Ugajin, K; Umezu, S	1
Hirai, K; Hiramatsu, K; Kishi, K; Murakami, J; Nasu, M; Yamasaki, T	1
Min, YH	1

Other Studies

6 other study(ies) available for clindamycin and rokitamycin

Article	Year
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
In vitro activity of YM133, a new semisynthesized macrolide. Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:7 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Clindamycin; Drug Resistance, Microbial; Erythromycin; Josamycin; Microbial Sensitivity Tests; Miocamycin; Oleandomycin	1991
In vitro activity of tetracyclines, macrolides, quinolones, clindamycin and metronidazole against periodontopathic bacteria. Journal of periodontal research, 1995, Volume: 30, Issue:4 Topics: Aggregatibacter actinomycetemcomitans; Anti-Bacterial Agents; Anti-Infective Agents; Antitrichomonal Agents; Clindamycin; Erythromycin; Fluoroquinolones; Metronidazole; Microbial Sensitivity Tests; Minocycline; Miocamycin; Naphthyridines; Ofloxacin; Porphyromonas gingivalis; Prevotella intermedia; Quinolones; Tetracycline	1995
[Antimicrobial activities of roxithromycin against recently obtained clinical isolates]. The Japanese journal of antibiotics, 1997, Volume: 50, Issue:7 Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cephalosporins; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Humans; Leucomycins; Methicillin Resistance; Miocamycin; Moraxella catarrhalis; Mycoplasma pneumoniae; Penicillin Resistance; Penicillins; Roxithromycin; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus agalactiae; Streptococcus pneumoniae; Streptococcus pyogenes	1997
Macrolides and clindamycin suppress the release of Shiga-like toxins from Escherichia coli O157:H7 in vitro. International journal of antimicrobial agents, 2000, Volume: 15, Issue:2 Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Cefdinir; Cephalosporins; Chlorocebus aethiops; Clindamycin; Dose-Response Relationship, Drug; Escherichia coli O157; Fosfomycin; Humans; Latex Fixation Tests; Levofloxacin; Microbial Sensitivity Tests; Miocamycin; Ofloxacin; Roxithromycin; Shiga Toxin 1; Shiga Toxin 2; Time Factors; Vero Cells	2000
Solithromycin Can Specifically Induce Macrolide-Lincosamide-Streptogramin B Resistance. Microbial drug resistance (Larchmont, N.Y.), 2020, Volume: 26, Issue:9 Topics: Anti-Bacterial Agents; Bacillus subtilis; Bacterial Proteins; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Escherichia coli; Gene Expression Regulation, Bacterial; Genes, Reporter; Genetic Engineering; Ketolides; Lac Operon; Lincosamides; Macrolides; Methyltransferases; Microbial Sensitivity Tests; Miocamycin; Staphylococcus aureus; Streptogramin B; Transformation, Bacterial; Triazoles	2020